Cite
HARVARD Citation
Del Mastro, L. et al. (2022). Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Lancet oncology. 23 (12), pp. 1571-1582. [Online].